Ephedrine
3produits homologués
1 monographie
Tablet, Capsule
Monographies de Santé Canada
1Plages de doses approuvées
1| Population | Plage de doses | Fréquence |
|---|---|---|
| Adolescents 12 to 17 years and adults 18 years and older | 8–32 milligrams | per day |
Mises en garde et contre-indications
8cautionKeep out of reach of children
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use, if you are pregnant or breastfeeding (Hackman et al. 2006; Kuczkowski 2006; Mills and Bone 2005; Coffey et al. 2004; Greenway et al. 2004; Haller et al. 2004; Hoffman 2003; Boozer et al. 2002; Boozer et al. 2001; Brinker 2001; Kalman et al. 2000).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking medication and/or natural health products for allergy symptoms, asthma, cough/cold or weight control (Hackman et al. 2006; Mills and Bone 2005; Naik and Freudenberger 2004; Boozer et al. 2002; Boozer et al. 2001).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking other products containing caffeine, ephedrine, phenylpropanolamine or pseudoephedrine (Brinker 2018; Hackman et al. 2006; Mills and Bone 2005; Naik and Freudenberger 2004; Boozer et al. 2002; Brinker 2001; Haller and Benowitz 2000; Kalman et al. 2000).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have cardiovascular disease, diabetes, difficulty in urination due to prostate enlargement, glaucoma, thyroid problems, seizure disorders or a pre-existing psychiatric condition (Hackman et al. 2006; Mills and Bone 2005; Bensky et al. 2004; Coffey et al. 2004; Greenway et al. 2004; Haller et al. 2004; Hioki et al. 2004; Hoffman 2003; Williamson 2003; Boozer et al. 2002; Boozer et al. 2001; Brinker 2001; Blumenthal et al. 2000; Kalman et al. 2000; BHP 1983).
contraindicationDo not use this product if you are taking, or have taken monoamine oxidase inhibitors in the past two weeks (Brinker 2018; Greenway et al. 2004; Hoffman 2003; Brinker 2001; Blumenthal et al. 2000; Kalman et al. 2000; Dingemanse et al. 1996; Dawson et al. 1995; Elis et al. 1967).
adverse_reactionStop use in case of restlessness, irritability, dizziness, tremor, severe headache, insomnia, loss of appetite, nausea, rapid heartbeat, shortness of breath and/or disturbance of urination (Mills and Bone 2005; Bensky et al. 2004; Mehendale et al. 2004; Shekelle et al. 2003; Boozer et al. 2001; Blumenthal et al. 2000; McGuffin et al. 1997; Astrup et al. 1992).
Noms alternatifs
6Ephedrine(common)l-Ephedrine(common)(1R,2S)-2-Methylamino-1-phenylpropan-1-ol(alphaR)-alpha-[(1S)-1-(Methylamino)ethyl]-benzenemethanol[R-(R*,S*)]-alpha-[1-(Methylamino)ethyl]-benzenemethanoll-Ephedrine
Quantités courantes dans les produits homologués
18 mg3 produits homologués
Ingrédients connexes
5Vérifiez la conformité de votre produit contenant Ephedrine
Validez votre formulation contre les monographies de Santé Canada et 3 produits homologués contenant Ephedrine.
Analyser gratuitement